• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TTNP

TTNP

Titan Pharmaceuticals, Inc.

NASDAQHealthcareBiotechnologyKY

USD2.34

-0.30 (-11.36%)

Company Profile

CEO

Weei Jye Chay

IPO Date

1996-01-18

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

KY

Market Metrics

Open

$2.55

Prev. Close

$2.64

Day Low

$2.30

Day High

$2.69

52W Low

$2.33

52W High

$15.15

Market Cap

$0.00B

Volume

0.13M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

37.0%

Avg Negative

1.9%

Avg Neutral

61.1%

News Feed

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus

PRNewsWire·6/23/2021·↑ positive

Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K

PRNewsWire·3/31/2021·↓ negative

TTNP Stock Price Increases Over 15% Pre-Market: Why It Happened

Pulse2·2/18/2021
·↓ negative

Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program

PRNewsWire·2/1/2021·↑ positive

Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering

PRNewsWire·1/15/2021·↑ positive

Titan Pharmaceuticals Announces Reverse Stock Split

PRNewsWire·11/30/2020·↑ positive

TTNP Stock Price Increases 34.75%: Why It Happened

Pulse2·11/20/2020·↑ positive

Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results

PRNewsWire·11/16/2020·↑ positive

Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

PRNewsWire·10/28/2020·↑ positive

Titan Pharmaceuticals News: 8 Things for TTNP Stock Investors to Know about the JT Pharma Deal

InvestorPlace·10/28/2020·↑ positive